GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of transcription elongation by RNA polymerase II | ||
protein phosphorylation | ||
hemopoiesis | ||
alternative mRNA splicing, via spliceosome | ||
negative regulation of stem cell differentiation |
GO Term | Evidence Code | PMID |
---|---|---|
Golgi apparatus | ||
nuclear speck | ||
cyclin/CDK positive transcription elongation factor complex | ||
nuclear cyclin-dependent protein kinase holoenzyme complex | ||
extracellular region |
GO Term | Evidence Code | PMID |
---|---|---|
protein binding | ||
protein serine kinase activity | ||
cyclin binding | ||
protein kinase binding | ||
cyclin-dependent protein serine/threonine kinase activity |
Gene Ontology |
---|
ATP binding |
RNA polymerase II CTD heptapeptide repeat kinase activity |
kinase activity |
nucleotide binding |
phosphorylation |
transferase activity |
InterPro |
---|
Protein kinase domain |
Protein kinase, ATP binding site |
Protein kinase-like domain superfamily |
Serine/threonine-protein kinase, active site |
DO ID | Disease Name | Source |
---|---|---|
DOID:0112247 | congenital heart defects, dysmorphic facial features, and intellectual developmental disorder | |
DOID:10283 | prostate cancer | |
DOID:10286 | prostate carcinoma | |
DOID:1059 | intellectual disability | |
DOID:1612 | breast cancer | |
DOID:684 | hepatocellular carcinoma |
Species | Gene ID | OrthoDB | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|---|
40385 | FB:FBgn0037093 | |||
69562 | MGI:1916812 | |||
175559 | WB:WBGene00007135 | |||
306998 | RGD:1311226 | |||
736969 | 9598_0:00208c | PANTR40109 | ||
853718 | SGD:S000001622 | |||
100444607 | 9601_0:001f60 | |||
100489599 | Xenbase:XB-GENE-6040279 | |||
100987832 | 9597_0:002144 | |||
101150971 | 9595_0:0024db |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024